← All trials
NCT05693181
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 5, 2022
- Primary completion
- Dec 31, 2024
- Completion date
- Aug 30, 2025
- First posted
- Jan 20, 2023
- Last posted
- Jan 20, 2023
- Enrollment
- 80
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Government of RussiaLead sponsor
- Government of RussiaReponsible party - principal investigator
- Medical Centre DinastyCollaborator
- Government of RussiaSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.